Screening for fragile X syndrome in women of reproductive age

Prenat Diagn. 2000 Aug;20(8):611-4. doi: 10.1002/1097-0223(200008)20:8<611::aid-pd881>3.0.co;2-m.

Abstract

We conducted a prospective intervention study of screening for fragile X syndrome in the general population. Antenatal and preconceptional screening were carried out in 9459 women aged between 19 and 44 with no known family history of fragile X syndrome. 80% were tested antenatally. 134 carriers were detected (a frequency of 1 in 70); 130 had a premutation (PM) and 4 had a full mutation (FM). Prenatal diagnosis was carried out in 108 concurrent or subsequent pregnancies among carriers involving 111 fetuses. Nine had an FM, a rate of 1 in 12; two of the affected embryos received the FM directly from the mother and in seven it was the result of expansion from a PM. In all cases with an FM the pregnancy was terminated. In PM carriers there was evidence of a selection against the mutated chromosome with a segregation ratio of 0.40. Owing to the high rate of premutated chromosomes in our population we conclude that screening for fragile X syndrome among women of reproductive age should be more widely available.

MeSH terms

  • Adult
  • DNA / blood
  • DNA Mutational Analysis
  • Female
  • Fetal Diseases / diagnosis
  • Fetal Diseases / genetics
  • Fragile X Syndrome / diagnosis*
  • Fragile X Syndrome / genetics*
  • Genetic Carrier Screening
  • Humans
  • Male
  • Pregnancy
  • Prenatal Diagnosis
  • Prospective Studies
  • Sex Ratio
  • Twins

Substances

  • DNA